Virological and immunological characteristics of fatal Epstein-Barr virus mononucleosis in a 17-year-old Caucasian male presenting with meningoencephalitis and hemophagocytic syndrome

References

• Attarbaschi T, Willheim M, Ramharter M, Hofmann A, Wahl K, Winkler H, Graninger W, Winkler S. T cell cytokine profile during primary Epstein-Barr virus infection (infectious mononucleosis). Eur Cytokine Netw 2003; 14: 34–39
   PubMed Web of Science ®Google Scholar
• Christensen T. The role of EBV in MS pathogenesis. Int Mult Scler J 2006; 13: 52–57
   Google Scholar
• Doja A, Bitnun A, Jones E L, Richardson S, Tellier R, Petric M, Heurter H, Macgregor D. Pediatric Epstein-Barr virus-associated encephalitis: 10-year review. J Child Neurol 2006; 21: 385–391
   Web of Science ®Google Scholar
• Drebber U, Kasper H U, Krupacz J, Haferkamp K, Kern M A, Steffen H M, Quasdorff M, zur Hausen A, Odenthal M, Dienes H P. The role of Epstein-Barr virus in acute and chronic hepatitis. J Hepatol 2006; 44: 879–885
   PubMed Web of Science ®Google Scholar
• Francisci D, Sensini A, Fratini D, Moretti M V, Luchetta M L, Di Caro A, Stagni G, Baldelli F. Acute fatal necrotizing hemorrhagic encephalitis caused by Epstein-Barr virus in a young adult immunocompetent man. J NeuroVirol 2004; 10: 414–417
   PubMed Web of Science ®Google Scholar
• Hinedi T B, Koff R S. Cholestatic hepatitis induced by Epstein-Barr virus infection in an adult. Dig Dis Sci 2003; 48: 539–541
   PubMed Web of Science ®Google Scholar
• Hiroshima K, Iyoda A, Isobe K, Ishii G, Toyozaki T, Shibuya K, Shimamura F, Haga Y, Okimoto Y, Horie H, Harigaya K, Ohwada H. Fatal infectious mononucleosis with evidence suggestive of the developmenot of B cell lymphoma. Pathol Int 2003; 53: 642–648
   PubMed Web of Science ®Google Scholar
• Hislop A D, Annels N E, Gudgeon N H, Leese A M, Rickinson A B. Epitope-specific evolution of human CD8+ T cell responses from primary to persistent phases of Epstein-Barr virus infection. J Exp Med 2002; 195: 893–905
   PubMed Web of Science ®Google Scholar
• Holmoy T, Kvale E O, Vartdal F. Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patients cross-recognize Epstein-Barr virus and myelin basic protein. J NeuroVirol 2004; 10: 278–283
   PubMed Web of Science ®Google Scholar
• Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 2002; 44: 259–272
   PubMed Web of Science ®Google Scholar
• Kasahara Y, Yachie A, Takei K, Kanegane C, Okada K, Ohta K, Seki H, Igarashi N, Maruhashi K, Katayama K, Katoh E, Terao G, Sakiyama Y, Koizumi S. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 2001; 98: 1882–1888
   PubMed Web of Science ®Google Scholar
• Khamma S, Kumar A. Infectious mononucleosis presenting as acute hepatitis, with marked leukocytosis and renal involvement. Indian J Gastroenterol 2003; 22: 62
   Google Scholar
• Kivisäkk P, Trebst C, Liu Z, Tucky B H, Sorensen T L, Rudick R A, Mack M, Ransohoff R M. T cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking. Clin Exp Immunol 2002; 129: 510–518
   PubMed Web of Science ®Google Scholar
• Kobbervig C, Norback D, Kahl B. Infectious mononucleosis progressing to fatal malignant lymphoma: a case report and review of the literature. Leuk Lymphoma 2003; 44: 1215–1221
   PubMed Web of Science ®Google Scholar
• Kumakura S. Hemophagocytic syndrome. Intern Med 2005; 4: 278–280
   Web of Science ®Google Scholar
• Lay J D, Tsao C J, Chen J Y, Kadin M E, Su I J. Upregulation of tumor necrosis factor-α gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest 1997; 100: 1969–1979
   PubMed Web of Science ®Google Scholar
• Lehrnbecher T, Chittka B, Nanan R, Seidenspinner S, Kreth H W, Schuster V. Activated T lymphocytes in the cerebrospinal fluid of a patient with Epstein-Barr virus-associated meningoencephalitis. Pediatr Infect Dis 1996; 15: 631–363
   Google Scholar
• Majid A, Galetta S L, Sweeney C J, Robinson C, Mahalingam R, Smith J, Forghani B, Gliden D H. Epstein-Barr virus myeloradiculitis and encephalomyeloradiculitis. Brain 2002; 125: 159–165
   PubMed Web of Science ®Google Scholar
• Markin R S. Manifestations of Epstein-Barr virus-associated disorders in liver. Liver 1994; 14: 1–13
   PubMedGoogle Scholar
• Merelli E, Bedin R, Sola P, Gentilini M, Pietrosemoli P, Meacci M, Portolani M. Encephalomyeloradiculopathy associated with Epstein-Barr virus: primary infection or reactivation?. Acta Neurol Scand 1997; 96: 416–420
   PubMed Web of Science ®Google Scholar
• Mizuno I, Takanashi Y, Onodera H, Shigeta M, Tanaka N, Yuya H, Kitaichi M, Nakajima K. A case of lymphomatoid granulomatosis/angiocentric immunoproliferative lesions with long clinical course and diffuse brain involvement. J Neurol Sci 2003; 213: 67–76
   PubMed Web of Science ®Google Scholar
• Negro F. The paradox of Epstein-Barr virus-associated hepatitis. J Hepatol 2006; 44: 839–841
   PubMed Web of Science ®Google Scholar
• Neuenburg J K, Cho T A, Nilsson A, Bredt B M, Hebert S J, Grant R M, Price R W. T-cell activation and memory phenotypes in cerebrospinal fluid during HIV infection. J Acquir Immune Defic Syndr 2005; 39: 16–22
   PubMed Web of Science ®Google Scholar
• Pelletier L L, Borel D M, Romig D A, Liu C. Disseminated intravascular coagulation and hepatic necrosis. Complications of infectious mononucleosis. JAMA 1976; 235: 1144–1146
   PubMed Web of Science ®Google Scholar
• Riemer G, Stenvik O, Dahl O P, Slungaard S, Ringstad J, Bruu A L. Encephalitis after acute Epstein-Barr virus infection. Tidsskr Nor Laegeforen 2001; 121: 1798–1800
   PubMedGoogle Scholar
• Sato S, Kawashima H, Oshiro H, Hasegawa D, Kashiwagi Y, Takekuma K, Hoshika A. Virological and immunological characteristics of a 19-year-old Japanese female with fatal outcome with Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Virol 2004; 31: 235–238
   PubMed Web of Science ®Google Scholar
• Schellinger P D, Sommer C, Leithauser F, Schwab S, Storch-Hagenlocher B, Hacke W, Kiessling M. Epstein-Barr virus meningoencephalitis with a lymphoma-like response in an immunocompetent host. Ann Neurol 1999; 45: 659–662
   PubMed Web of Science ®Google Scholar
• Tselis A, Duman R, Storch G A, Lisak R P. Epstein-Barr virus encephalomyelitis diagnosed by polymerase chain reaction: detection of the genome in the CSF. Neurology 1997; 48: 1351–1353
   PubMed Web of Science ®Google Scholar
• Yamashita S, Murakami C, Izumi Y, Sawada H, Yamazaki Y, Yokota T A, Matsumoto N, Matsukura S. Severe chronic active Epstein-Barr virus infection accompanied by virus-associated hemophagocytic syndrome, cerebellar ataxia and encephalitis. Psychiatry Clin Neurosci 1998; 52: 449–452
   PubMed Web of Science ®Google Scholar
• Zephir H, De Seze J, Ferriby D, Stojkovic T, Vermersch P. Epstein-Barr meningoencephaloradiculitis in a immunocompetent woman. Rev Neurol 2002; 158: 830–832
   PubMedGoogle Scholar
• Židovec Lepej S, Vince A, Dakovic Rode O, Remenar A, Jeren T. Increased numbers of CD38 molecules on bright CD8+ T lymphocytes in infectious mononucleosis caused by Epstein-Barr virus infection. Clin Exp Immunol 2003; 133: 384–390
   PubMed Web of Science ®Google Scholar